Park National Corp Amgen Inc Transaction History

Park National Corp

$2.82 Billion
Q3 2024

A detailed history of Park National Corp transactions in Amgen Inc stock. As of the latest transaction made, Park National Corp holds 2,210 shares of AMGN stock, worth $706,271. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,210

Previous 2,155 2.55%

Holding current value

$706,271

Previous $673,000 5.79%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	BUY	$309.38 - $337.38 $17,015 - $18,555	55 Added 2.55%	2,210 $712,000
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $19,180 - $23,309	-73 Reduced 3.28%	2,155 $673,000
Q1 2024 Apr 01, 2024	BUY	$268.87 - $324.56 $7,797 - $9,412	29 Added 1.32%	2,228 $633,000
Q4 2023 Jan 02, 2024	SELL	$255.7 - $288.46 $113,786 - $128,364	-445 Reduced 16.83%	2,199 $633,000
Q3 2023 Oct 02, 2023	BUY	$218.65 - $271.46 $6,559 - $8,143	30 Added 1.15%	2,644 $710,000
Q2 2023 Jul 03, 2023	BUY	$214.27 - $253.37 $9,642 - $11,401	45 Added 1.75%	2,614 $580,000
Q1 2023 Apr 03, 2023	BUY	$225.79 - $275.2 $32,062 - $39,078	142 Added 5.85%	2,569 $621,000
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $53,593 - $68,096	-234 Reduced 8.79%	2,427 $637,000
Q3 2022 Oct 03, 2022	SELL	$224.46 - $253.15 $85,743 - $96,703	-382 Reduced 12.55%	2,661 $599,000
Q2 2022 Jul 01, 2022	SELL	$230.71 - $256.74 $230 - $256	-1 Reduced 0.03%	3,043 $740,000
Q1 2022 Apr 01, 2022	SELL	$219.27 - $242.57 $877 - $970	-4 Reduced 0.13%	3,044 $736,000
Q4 2021 Jan 04, 2022	SELL	$198.88 - $227.6 $159,104 - $182,080	-800 Reduced 20.79%	3,048 $686,000
Q3 2021 Oct 01, 2021	SELL	$212.27 - $248.7 $42,454 - $49,740	-200 Reduced 4.94%	3,848 $818,000
Q2 2021 Jul 01, 2021	SELL	$233.58 - $259.14 $67,271 - $74,632	-288 Reduced 6.64%	4,048 $986,000
Q1 2021 Apr 01, 2021	SELL	$221.91 - $258.6 $347,289 - $404,709	-1,565 Reduced 26.52%	4,336 $1.08 Million
Q4 2020 Jan 04, 2021	SELL	$216.38 - $257.67 $11,468 - $13,656	-53 Reduced 0.89%	5,901 $1.36 Million
Q3 2020 Oct 01, 2020	SELL	$234.65 - $260.95 $209,542 - $233,028	-893 Reduced 13.04%	5,954 $1.51 Million
Q2 2020 Jul 01, 2020	SELL	$197.81 - $242.74 $2,373 - $2,912	-12 Reduced 0.17%	6,847 $1.62 Million
Q1 2020 Apr 01, 2020	SELL	$182.24 - $241.7 $88,750 - $117,707	-487 Reduced 6.63%	6,859 $1.39 Million
Q4 2019 Jan 02, 2020	BUY	$189.21 - $243.2 $4,919 - $6,323	26 Added 0.36%	7,346 $1.77 Million
Q3 2019 Oct 01, 2019	SELL	$174.11 - $208.62 $26,116 - $31,293	-150 Reduced 2.01%	7,320 $1.42 Million
Q2 2019 Jul 01, 2019	SELL	$166.7 - $195.41 $28,672 - $33,610	-172 Reduced 2.25%	7,470 $1.38 Million
Q1 2019 Apr 01, 2019	SELL	$180.87 - $203.88 $13,926 - $15,698	-77 Reduced 1.0%	7,642 $1.45 Million
Q4 2018 Jan 02, 2019	SELL	$178.4 - $208.25 $1,784 - $2,082	-10 Reduced 0.13%	7,719 $1.5 Million
Q3 2018 Oct 02, 2018	SELL	$185.29 - $208.89 $88,753 - $100,058	-479 Reduced 5.84%	7,729 $1.6 Million
Q2 2018 Jul 02, 2018	SELL	$166.05 - $186.51 $65,921 - $74,044	-397 Reduced 4.61%	8,208 $1.52 Million
Q1 2018 Apr 02, 2018	SELL	$169.43 - $198.0 $105,385 - $123,156	-622 Reduced 6.74%	8,605 $1.47 Million
Q4 2017 Jan 02, 2018	SELL	$168.79 - $188.59 $154,105 - $172,182	-913 Reduced 9.0%	9,227 $1.61 Million
Q3 2017 Oct 02, 2017	BUY	$167.29 - $191.0 $1.7 Million - $1.94 Million	10,140	10,140 $1.89 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Amgen Inc Transaction History